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Table. Multivariate analysis of factors associated with 1-year AFS after
PVI (N ¼ 771)
Preoperative characteristic
Hazard
ratio
95% Conﬁdence
interval P value
Dialysis 2.9 2.0-4.2 <.01
Tissue loss 1.8 1.2-2.7 <.01
Dependent living status 1.8 1.1-2.9 .02
Male gender 1.6 1.2-2.1 .01
Congestive heart failure 1.5 1.2-2.0 <.01
Age >80 years 1.4 1.0-1.9 .049
Smoking (prior or current) 0.6 0.5-0.9 <.01
AFS, Amputation-free survival; PVI, peripheral vascular intervention.
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Volume 58, Number 3 Abstracts 855Methods: We performed a cost-effectiveness analysis comparing SE
and ilio-femoral PS with a baseline strategy of nonsupervised exercise
(NSE). Estimates for costs and outcomes were obtained from the
medical literature (Table) and the Bureau of Labor Statistics. Costs
were adjusted to 2012 US Dollars. Effectiveness was measured as the
maximum walking distance (MWD) in meters by treadmill testing per-
formed at 1-year. The primary endpoint was cost-effectiveness measured
in dollars per meter walked. Because of a 1-year time horizon, discount-
ing was not used.
Results: The average cost-effectiveness of NSE/SE/PS in dollars per
meter walked was 15.4/19.8/51.6, respectively. When compared with
NSE, the incremental cost-effectiveness ratio for SE was $24.96/m. For
PS, it was $81.1/m. One-way sensitivity analyses (Table, Column 3)
demonstrated that SE was a robust strategy in that it was more cost-effective
than PS in all scenarios. PS was both more costly and less effective (ie, domi-
nated) if MWDPS <207 m or MWDSE >424 m.
Conclusion: When compared with NSE, SE is a more cost-effective
strategy than PS for the treatment of iliofemoral disease in IC.Determinants of Amputation-Free Survival After Peripheral Vascular
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Objectives: Our objective was to identify independent predictors
of overall (OS) and amputation-free survival (AFS) in patients under-
going peripheral vascular intervention (PVI) for critical limb ischemia
(CLI).
Methods: We reviewed 1253 patients who underwent 1414 PVI for
CLI within the Vascular Study Group of New England (VSGNE) from
January 2010 to December 2011. A univariate screen of potential predictors
of the primary (AFS) and secondary (OS) end points was performed to
construct a Cox proportional hazards model of survival at 1 year.
Results: All PVI were performed for CLI (rest pain 29%, tissue loss
71%). During each procedure, the number of arteries treated were one
(49%), two (35%), three (12%) and >four (5%). Target arterial segments
and TASC classiﬁcations were aorto-iliac (27%; A 49%, B 25%, C 11%, D
15%), femoral-popliteal (48%; A 30%, B 33%, C 20%, D 17%) and infrapopli-
teal (25%; A 17%, B 15%, C 27%, D 41%). Technical success was high (92%),
while complication rates were low (access site hematoma [5.0%] or occlusion
[0.3%], distal embolization [2.4%]). Mortality and major amputation rates
were 2.8% and 2.2% at 30 days, respectively. Overall percutaneous or open
reintervention rate was 8.0% at 1 year. The Kaplan-Meier estimates of 1-
year OS and AFS were 82% and 76%, respectively. Independent predictors
of AFS included male gender, age>80 years, dependent living status,congestive heart failure, dialysis dependence, and tissue loss; smoking was
protective (Table).
Conclusions: AFS after PVI for CLI is associated with speciﬁc preop-
erative patient characteristics. This data may facilitate efforts to improve
patient selection and, after further validation, enable risk-adjusted outcome
reporting for CLI patients undergoing PVI.Predictors of Increased Length of Stay Following Endovascular AAA
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Objectives: Increased length of stay (LOS) following abdominal
aortic aneurysm (AAA) repair increases costs of care and serves as an impor-
tant quality metric. We sought to identify patient and procedural factors
associated with increased postoperative LOS following endovascular aneu-
rysm repair (EVAR).
Methods: All consecutive EVAR patients from a single institution (1/
2010-10/2012) were evaluated for increased LOS, deﬁned as >2 days.
Predictors of increased LOS were identiﬁed by univariate and multivariate
analysis.
Results: We identiﬁed 257 EVAR patients. Increased LOS was
observed in 63% of patients. Univariate analysis showed that patients with
increased LOS were older (78 6 10 vs 73 6 8 years; P < .01), female (27%
vs 14%; P¼ .01), smokers (88% vs 77%; P¼ .03), had coronary artery disease
(35% vs. 18%; P< .01), chronic obstructive pulmonary disease (36% vs 13%; P
< .01), prior AAA repair (11% vs 3%; P¼ .04), elevated creatinine>1.5 mg/
dL (16% vs 7%; P ¼ .05), and larger AAA (59 6 13 mm vs 54 6 8 mm;
P < .01). They were more likely to have general anesthesia (59% vs 44%;
P ¼ .03), longer operating room time (190 6 80 vs 130 6 40 minutes;
P < .01), receive more volume (1960 6 980 vs 1670 6 780 mL; P ¼ .02),
and have higher estimated blood loss (330 6 320 vs 190 6 140 mL; P <
.01). Patients staying >2 days were more likely to require vasopressors (11%
vs 3.4%; P ¼ .05), intensive care unit stay (20% vs 1%; P < .01), and return
to the operating room (5% vs 0%; P ¼ .03). Despite these differences, risk
adjusted independent predictors of increased LOS following EVAR included
symptomatic coronary artery disease (odds ratio [OR] 2.3; 95% conﬁdence
interval [CI], 1.2-4.7; P ¼ .01), chronic obstructive pulmonary disease (OR,
3.4; 95% CI, 1.4-7.9; P < .01), procedure time (per minute; OR, 1.02; 95%
CI, 1.01-1.03; P < .01), age (per year; OR, 1.04; 95% CI, 1.01-1.09; P ¼
.01), while preoperative statin use (OR, 0.29; 95% CI, 0.1-0.6; P < .01),
anddischarge to home (OR,0.07; 95%CI, 0.01-0.48;P< .01)was protective.
Chi-Pi analysis showed that both procedure time (33%) and disposition (26%)
combined accounted for more than half of the increased LOS.
Conclusions: These data highlight clinical and technical variables
associated with increased LOS following EVAR and may be utilized to enact
process improvement measures to improve patient care and reduce hospital
costs.Are Meta-Analyses and Systematic Reviews in Vascular Surgery
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Objectives: Meta-analyses (MAs) and systematic reviews (SRs) are
considered the highest level of evidence by the Oxford Centre for Evidence-
Based Medicine. The evidence-based minimum set of “Preferred Reporting
Items for Systematic Reviews andMeta-Analyses” (PRISMA) was introduced
in 2009. The objective of this protocol-driven study was to evaluate the
quality of MAs and SRs published in the Journal of Vascular Surgery.
